<SEC-DOCUMENT>0001129928-16-000019-index.html : 20161103
<SEC-HEADER>0001129928-16-000019.hdr.sgml : 20161103
<ACCEPTANCE-DATETIME>20161103141949
ACCESSION NUMBER:		0001129928-16-000019
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160930
FILED AS OF DATE:		20161103
DATE AS OF CHANGE:		20161103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31062
		FILM NUMBER:		161971130

	BUSINESS ADDRESS:	
		STREET 1:		1167 KENSINGTON CRES NW SUITE 210
		STREET 2:		CALGARY ALBERTA CANADA T2N 1X7
		CITY:			ALBERTA CANADA
		STATE:			A0
		ZIP:			00000
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		210 - 1167 KENSINGTON CRES NW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2N 1X7
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>thirdquarter20166k.htm
<DESCRIPTION>THIRD QUARTER 2016
<TEXT>
Document 1 - file: thirdquarter20166k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991interimfinancialstate.htm
<DESCRIPTION>INTERIM FINANCIAL STATEMENTS SEPTEMBER 30, 2016
<TEXT>
Document 2 - file: ex991interimfinancialstate.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ex992-q32016mda.htm
<DESCRIPTION>INTERIM MD&A SEPTEMBER 30, 2016
<TEXT>
Document 3 - file: ex992-q32016mda.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image0a03.jpg
<TEXT>
Document 4 - file: image0a03.jpg

</DOCUMENT>
</SEC-DOCUMENT>